Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies
- 9 October 2013
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 28 (2), 444-447
- https://doi.org/10.1038/leu.2013.292
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Camelid single-domain antibody-fragment engineering for (pre)clinicalin vivomolecular imaging applications: adjusting the bullet to its targetExpert Opinion on Biological Therapy, 2013
- SPECT Imaging of Joint Inflammation with Nanobodies Targeting the Macrophage Mannose Receptor in a Mouse Model for Rheumatoid ArthritisJournal of Nuclear Medicine, 2013
- Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancerImmunobiology, 2012
- Targeted Therapy of Multiple MyelomaAdvances in experimental medicine and biology, 2012
- Development of 177Lu‐nanobodies for radioimmunotherapy of HER2‐positive breast cancer: evaluation of different bifunctional chelatorsContrast Media & Molecular Imaging, 2012
- Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patientsTumor Biology, 2012
- Growth inhibition of myeloma cells by anti‐idiotype antibodies in the absence of membrane‐bound immunoglobulinImmunology & Cell Biology, 2008
- Nanobodies as novel agents for cancer therapyExpert Opinion on Biological Therapy, 2005
- Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodiesLeukemia, 2002
- The 5TMM series: a useful in vivo mouse model of human multiple myelomaThe Hematology Journal, 2000